Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3

Inclusion Criteria

• •Parent of a child who is diagnosed and being treated for any type of acute lymphoblastic leukemia (ALL) at a study site.
• •Parent has primary medication responsibility.
• •Pediatric patient aged 3-9 years
• •Child on therapy that includes home-based oral anti-cancer medication, such as 6-MP.
• •Parent has verbal English or Spanish fluency.
• •Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure